+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Simultaneous determination of carbamazepine and carbamazepine 10,11-epoxide by using microcolumn HPLC: study of pharmacokinetics of carbamazepine in a volunteer



Simultaneous determination of carbamazepine and carbamazepine 10,11-epoxide by using microcolumn HPLC: study of pharmacokinetics of carbamazepine in a volunteer



Biomedical Chromatography 11(1): 36-41



A highly-sensitive microcolumn HPLC method for the simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide in human serum and saliva is described. The method was successfully employed for the study of pharmacokinetics of carbamazepine in humans. After oral administration of 100 and 200 mg of carbamazepine to a volunteer, multiple peaks were observed on the kinetic curves. They were symbathic in the serum and saliva. This indicated the presence of multiple peaks which characterize both free and protein-bound fractions of the drug. The existence of multiple peaks on the kinetic curves implies that the kinetic of carbamazepine cannot be described with the one-compartment linear model. Nevertheless, each peak was treated within the range of a one-compartment linear model of absorption and the results obtained were compared with published data. For the elucidation of the nature of multiple peaks the graphical differentiation of ascending and descending branches of all peaks were carried out. On this basis of the dependence of the absorption and elimination rates on time was constrained. The analysis of experimental data resulted in the following conclusions: (a) the presence of multiple peaks on the kinetic curves is induced by the interrupted character of carbamazepine absorption that is caused by the very poor solubility of carbamazepine; (b) the elimination of the drug from blood serum occurs in two phases. Binding of carbamazepine with tissues takes place in the first phase, and biotransformation and excretion occurs in the second phase. It is possible that the presence of multiple peaks on the kinetic curves is partially caused also by redistribution of the drug from the comparatively easily accessible to the less accessible tissues. This requires further investigation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009419317

Download citation: RISBibTeXText

PMID: 9051215

DOI: 10.1002/(sici)1099-0801(199701)11:1<36::aid-bmc622>3.0.co;2-1


Related references

A PLS-based extractive spectrophotometric method for simultaneous determination of carbamazepine and carbamazepine-10, 11-epoxide in plasma and comparison with HPLC. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 68(3): 718-724, 2007

Simultaneous separation and determination of zonisamide, phenytoin carbamazepine and carbamazepine 10, 11-epoxide in human plasma using isocratic reversed-phase HPLC. Fudan Xuebao 34(4): 603-607, 2007

Application of thermospray liquid chromatography-mass spectrometry to the simultaneous quantification of tracer concentrations of isotopically labelled carbamazepine epoxide and steady-state levels of carbamazepine and carbamazepine epoxide. Journal of Chromatography 474(1): 223-230, 1989

Simultaneous HPLC analysis of carbamazepine and carbamazepine epoxide in human brain microdialysate. Journal of Liquid Chromatography 17(7): 1567-1576, 1994

A validated HPLC method for the determination of carbamazepine and carbamazepine 10,11-epoxide in human plasma. Journal Of Liquid Chromatography. 16(6): 1249-1261, 1993

Concomitant HPLC method for determination of lamotrigine, carbamazepine, and 10,11-carbamazepine epoxide in plasma using dual UV 240-220 nm wavelength detection. Journal of Liquid Chromatography & Related Technologies 24(20): 3171-3180, 2001

Effects of carbamazepine on hepatic glutathione level in rats and determination of carbamazepine and its epoxide metabolite in plasma by HPLC. Drug Metabolism and Drug Interactions 14(4): 251-258, 2000

Effects of carbamazepine on hepatic glutathione level in rats and determination of carbamazepine and its epoxide metabolite in plasma in HPLC. Drug Metabolism & Drug Interactions 14(4): 251-258, 1998

Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide. Pharmaceutical Research 7(5): 513-517, 1990

Rapid HPLC-MS/MS Determination of Carbamazepine and Carbamazepine-10,11-Epoxide. Pharmaceutical Chemistry Journal 50(6): 419-423, 2016

Simultaneous Determination of Carbamazepine and its Active Metabolite Carbamazepine-10,11-epoxide in Human Plasma by UPLC. Chromatographia 66(1): 123-127, 2007

Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 41(4): 1386-1390, 2006

First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 925: 1-9, 2013

Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human plasma by high-performance liquid chromatography with ultraviolet detection. Journal of Pharmaceutical & Biomedical Analysis 16(7): 1233-1240, 1998

Simultaneous high performance liquid-chromatographic determination of carbamazepine, carbamazepine-10,11-epoxide, ethosuximide, phenobarbital, phenytoin, primidone and phenylethylmalonamide in plasma. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 21(5): 295-299, 1983